Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 16.500 | 16.500 | 0.000 |
Stocks | 87.230 | 87.230 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.018 | 24.691 |
Price to Book | 2.702 | 3.269 |
Price to Sales | 1.164 | 4.110 |
Price to Cash Flow | 11.074 | 17.419 |
Dividend Yield | 2.124 | 1.322 |
5 Years Earnings Growth | 19.661 | 18.917 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.440 | 97.322 |
Consumer Cyclical | 0.560 | 0.370 |
Number of long holdings: 31
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
WuXi AppTec | CNE1000031K4 | 8.85 | 42.11 | +0.41% | |
Chongqing Zhifei Bio Products | CNE100000V20 | 8.45 | 32.79 | -0.12% | |
Shenzhen Mindray Bio-Medical | CNE100003G67 | 8.35 | 295.36 | -1.03% | |
Zhejiang Jiuzhou Pharm | CNE100001W36 | 6.62 | 15.09 | -0.33% | |
Jiangsu Hengrui | CNE0000014W7 | 6.07 | 42.36 | -1.21% | |
Jointown Pharm | CNE100000W45 | 5.79 | 7.40 | -0.40% | |
Humanwell Healthcare | CNE000000QW6 | 5.73 | 19.30 | -0.05% | |
Nhwa Pharma A | CNE100000CG8 | 4.93 | 23.84 | +2.49% | |
Kelun Pharm A | CNE100000PW7 | 3.95 | 32.07 | -0.71% | |
Shenzhen YHLO Biotech Co | CNE100005204 | 3.76 | 24.29 | +3.06% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Morgan Stanley Huaxin Multiple Fact | 562.55M | -11.44 | -8.54 | 8.06 | ||
MS Huaxin Resource Selected Mixed | 407.12M | 8.40 | -17.07 | 5.61 | ||
MS Huaxin Aggressive Growth Equity | 353.2M | -2.84 | -17.36 | - | ||
Huaxin Leading Advanced Stock | 300.41M | -7.23 | -6.41 | 9.49 | ||
Huaxin Excellent Growth Stock | 286.41M | -5.98 | -17.36 | 9.01 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review